Charity of the week: Multiple Myeloma Research Foundation

The MMRF pursues research to speed the development of next-generation treatments for multiple myeloma.

The Multiple Myeloma Research Foundation (TheMMRF.org) was established as a nonprofit organization in 1998 by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy’s diagnosis with multiple myeloma, the second most common blood cancer after non-Hodgkin’s lymphoma. Multiple myeloma represents about 1 percent of all cancers among white Americans and 2 percent of those among African-Americans; more than 22,000 new cases are expected to be diagnosed in the U.S. this year. The MMRF pursues innovative research to speed the development of next-generation treatments to extend the lives of multiple myeloma patients and eventually lead to a cure. As the world’s largest private funder of multiple myeloma research, the MMRF has raised over $225 million since its inception, 90 percent of which has been spent on research.

Each charity we feature has earned a four-star overall rating from Charity Navigator, which rates not-for-profit organizations on the strength of their finances, their control of administrative and fundraising expenses, and the transparency of their operations. Four stars is the group’s highest rating.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us